Something is brewing with this one, i expect a breakout soon.Many small announcements over the last few months no real significant ones. The price fairly steady and volume just beginning to increase.This one is a real sleeper.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%